THE 2-MINUTE RULE FOR API PHARMACEUTICAL

Such carryover should not end in the carryover of degradants or microbial contamination which could adversely alter the founded API impurity profile.Continuation of the procedure phase just after an in-approach Command examination has shown that the step is incomplete is regarded as part of the conventional procedure. It's not regarded as reprocess